malaria vaccines
MALVAC 2012 scientific forum: accelerating development of second generation malaria vaccines
... to malaria vac- cines, since human efficacy studies are both ethical and ...pre-erythrocytic malaria vaccines, it could only be used if the antigen were the same as in the first-generation vac- cine ...
10
Modeling the public health impact of malaria vaccines for developers and policymakers
... of malaria vaccines that are being considered or that are currently in research and development — for example, future versions of the model could include different efficacy levels, delivery strategies, or ...
15
European Vaccine Initiative: lessons from developing malaria vaccines.
... in malaria vac- cinology, the funding needed for Phase IV of RTS,S also gener- ates a difficult conundrum for the allocation of the existing scarce resources for malaria vaccine R&D: continuation and ...
12
Modelling population-level impact to inform target product profiles for childhood malaria vaccines
... other malaria vaccines could be undertaken to incorporate other factors such as antibody quality into this modelling framework, to consider the po- tential public health impact of candidate vaccines ...
11
Simulation of the cost effectiveness of malaria vaccines
... candidate malaria vaccines may help guide policy makers and vaccine developers, by providing addi- tional evidence that malaria vaccines may be efficient malaria control ...
17
Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines
... Inclusion of formulated GLA in the PfCelTOS vaccine composi- tion shapes the immune response toward a Th1 bias, as demon- strated by the production of significantly higher IgG2a antibody titers and IFN- ␥ levels. Total ...
8
WHO policy development processes for a new vaccine: case study of malaria vaccines
... This paper has taken the unique step of trying to iden- tify the data and processes required at the WHO policy level for the introduction of a new intervention. While the focus has been on SAGE and STAG processes for ...
11
Experience and challenges from clinical trials with malaria vaccines in Africa
... synthetic malaria vaccines ...to malaria vaccine candidates in develop- ment and gave insights into the relative proportion of cytophilic antibodies to non-cytophilic antibodies (the C: NC ratio) as ...
9
Progress in the development of recombinant and synthetic blood stage malaria vaccines
... human malaria for the purpose of investigating immunity induced by the asexual blood stage, and it is not possible to perform experimental human challenge with blood-stage parasites when assessing the protective ...
8
Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report
... Antibody reactivity to the surface of placental‑type infected erythrocytes by flow cytometry While antibodies that inhibit binding of placental type P. falciparum-infected erythrocytes to CSA appear to be a primary ...
11
Studies using transgenic rodent malaria parasites to improve live attenuated malaria vaccines
... in particular of vaccine strategies targeting pre-erythrocytic vaccines. The use of transgenic parasites may not only help to rank order existing candidates but also help to reveal novel vaccine candidate ...
225
A mathematical model of the impact of present and future malaria vaccines
... large reduction in An. arabiensis biting and almost com- plete reduction in the fraction of transmission from the more endophagic An. gambiae s.s. and An. funestus vec- tors. While the corresponding PEV-only scenario ...
13
Malaria vaccines and their potential role in the elimination of malaria
... seasonal malaria, where there is often a long dry season in which little or no transmission occurs, persisting very low gametocytaemias are the source from which transmission occurs at the onset of the subsequent ...
9
Utilization of genomic sequence information to develop malaria vaccines
... individual vaccines (Doolan et ...with vaccines based on only one or two of the four antigens ...DNA-based vaccines (Doolan and Hoffman, 2001; Moorthy and Hill, ...DNA vaccines have proved ...
14
Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
... of malaria, in 1,600 participants have been performed [23], indicat- ing that large clinical trials of malaria vaccines are pos- sible in malaria-endemic ...
8
Community perceptions of a malaria vaccine in the Kintampo districts of Ghana
... a malaria vaccine were virtually unknown in the study area, not even among religious ...new vaccines, such as malaria vaccines, since some known childhood immunizations such as OPV are given ...
10
Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity
... parasite vaccines provide a unique opportunity for dissecting immune mechanisms and iden‑ tify antigens that are targeted by immune responses which have the potential to mediate sterile protection against ...
7
Is vaccine the magic bullet for malaria elimination? A reality check
... annually. Vaccines have been proposed as a necessary addition to the armamentarium that could work towards elimination and eventual eradication of malaria in view of their histori- cal significance in ...
8
Emergence of multilateral proto-institutions in global health and new approaches to governance: analysis using path dependency and institutional theory
... Global Fund: Global Fund to Fight AIDS, Tuberculosis and Malaria; GAVI: Global Alliance for Vaccines Initiative; NGO: Non-governmental organization; BW: Bretton Woods; ADB: Asian Develop[r] ...
17
Contribution of the Japan International Cooperation Agency health-related projects to health system strengthening
... In order to understand the structure, function and performance of a health system, many researchers have developed health system models with interactive compo- nents and have assessed performance using various indi- ...
10